Transcriptomic Features of T Cell-Barren Tumors Are Conserved Across Diverse Tumor Types

Background: Understanding how tumors subvert immune destruction is essential to the development of cancer immunotherapies. New evidence suggests that tumors limit anti-tumor immunity by exploiting transcriptional programs that regulate intratumoral trafficking and accumulation of effector cells. Her...

Descripción completa

Detalles Bibliográficos
Autores principales: Routh, Eric D., Pullikuth, Ashok K., Jin, Guangxu, Chifman, Julia, Chou, Jeff W., D'Agostino, Ralph B., Seino, Ken-ichiro, Wada, Haruka, Print, Cristin G., Zhang, Wei, Lu, Yong, Miller, Lance D.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031496/
https://www.ncbi.nlm.nih.gov/pubmed/32117236
http://dx.doi.org/10.3389/fimmu.2020.00057

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7031496/
https://www.ncbi.nlm.nih.gov/pubmed/32117236
http://dx.doi.org/10.3389/fimmu.2020.00057

Ejemplares similares